Home » Topics » BioWorld Science

BioWorld Science
RSS

Maxi-K channel modulators from Bayer

May 3, 1996

Berlex attempts to block approval of Avonex in U.S.

May 3, 1996

Pola describes dopamine reuptake inhibitors for Parkinson's disease

May 3, 1996

Astrotactin-producing gene may aid in understanding of epilepsy

May 3, 1996

OncoRx gets new identity: Vion Pharmaceuticals

May 3, 1996

Sandoz to acquire Imutran

May 3, 1996

Bristol-Myers Squibb opens R&D office in Russia

May 3, 1996

Hafslund Nycomed demerger imminent

May 3, 1996

Gensia coagulation monitoring system enters phase I

May 3, 1996

Stealth liposomes possess prolonged stability

May 3, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 27, 2026.
Brain-penetrant NLRP3 inhibitor shows promise in Parkinson’s
BioWorld Science
Researchers from Changchun Genescience Pharmaceuticals Co. Ltd. described the discovery and preclinical profile of an NLRP3 inhibitor with favorable brain...
4D Nucleome opens new wave of gene regulation research, discovery
BioWorld
After a decade of research, the NIH 4D Nucleome program on July 23 delivered a wealth of new insights into how spatial changes in chromatin structure and DNA...
Daybu readthrough in EU? Zevra’s NPC bid flounders
BioWorld
Zevra Therapeutics Inc. will try to follow in the footsteps of Acadia Pharmaceuticals Inc. with Rett syndrome drug Daybu (trofinetide) by asking the EMA’s...
Transcripta Bio raises funding to advance neuro pipeline
BioWorld Science
Transcripta Bio Inc. has raised $24 million since its series A to fund IND-enabling studies across its portfolio and support clinical preparation in its autism...